Peptide Mutation Policy for MHC Binding Generation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current computational tools lack the ability to generate new peptide sequences with specified binding properties for MHC proteins, which are crucial for immunotherapy applications such as targeting viruses and tumors.

Innovation Solution

A machine learning model is trained to predict and generate modifications to peptide sequences using a mutation policy, embedding peptide and protein states as vectors, and employing reinforcement learning to increase the presentation score, thereby producing new peptides with enhanced binding affinity to MHC proteins.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If computational tools are used to predict peptide-MHC binding interactions, then binding affinity prediction is achieved, but the ability to generate new peptides with specified binding properties is lacking

Engineering Contradiction:
Improveability to generate new peptides with specified binding propertiesVSAvoidcomputational tool complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

A mutation policy model serves as an intermediary between existing peptide-MHC binding prediction tools and the generation of new peptides with specified properties. The model learns optimal mutation strategies from training data and applies them to generate novel peptides, bridging the gap between prediction capabilities and generative capabilities without requiring complete redesign of computational infrastructure

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The mutation policy model is trained in advance on a dataset of known peptide-MHC bindings to learn effective mutation patterns. This preliminary training phase enables the model to subsequently generate new peptides with desired binding properties by applying learned mutation strategies, rather than requiring complex real-time optimization during peptide generation

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS20220327425A1Peptide mutation policies for targeted immunotherapy
Publication Date: 2022.10.13 NEC LABORATORIES AMERICA INC
  • US20220327425A1 patent drawing
  • US20220327425A1 patent drawing
  • US20220327425A1 patent drawing

AI summary

Methods and systems for training a machine learning model include embedding a state, including a peptide sequence and a protein, as a vector. An action, including a modification to an amino acid in the peptide sequence, is predicted using a presentation score of the peptide sequence by the protein as a reward. A mutation policy model is trained, using the state and the reward, to generate modifications that increase the presentation score.